Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 6318 | 1434 | 47.7 | 90% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 370 | 16580 | NITRIC OXIDE//PEROXYNITRITE//NITRIC OXIDE-BIOLOGY AND CHEMISTRY |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | COLLAGENOUS PROTEIN BIOSYNTHESIS | Author keyword | 2 | 67% | 0% | 2 |
| 2 | NOS3 | Author keyword | 2 | 13% | 1% | 12 |
| 3 | IMMUNOL IMMUNOTHER IE CANC | Address | 1 | 38% | 0% | 3 |
| 4 | CGMP PKG PATHWAY | Author keyword | 1 | 100% | 0% | 2 |
| 5 | ENDOGENOUS RISK TORS GRP | Address | 1 | 100% | 0% | 2 |
| 6 | INFLAMMATORY DRIVEN CARCINOGENESIS | Address | 1 | 100% | 0% | 2 |
| 7 | NEOPLASTIC LYMPHOID CELLS | Author keyword | 1 | 100% | 0% | 2 |
| 8 | NITRIC OXIDE DONATING DRUG | Author keyword | 1 | 100% | 0% | 2 |
| 9 | PL PHYSIOL BRANCH | Address | 1 | 100% | 0% | 2 |
| 10 | DMBA CARCINOGENESIS | Author keyword | 1 | 29% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | COLLAGENOUS PROTEIN BIOSYNTHESIS | 2 | 67% | 0% | 2 | Search COLLAGENOUS+PROTEIN+BIOSYNTHESIS | Search COLLAGENOUS+PROTEIN+BIOSYNTHESIS |
| 2 | NOS3 | 2 | 13% | 1% | 12 | Search NOS3 | Search NOS3 |
| 3 | CGMP PKG PATHWAY | 1 | 100% | 0% | 2 | Search CGMP+PKG+PATHWAY | Search CGMP+PKG+PATHWAY |
| 4 | NEOPLASTIC LYMPHOID CELLS | 1 | 100% | 0% | 2 | Search NEOPLASTIC+LYMPHOID+CELLS | Search NEOPLASTIC+LYMPHOID+CELLS |
| 5 | NITRIC OXIDE DONATING DRUG | 1 | 100% | 0% | 2 | Search NITRIC+OXIDE+DONATING+DRUG | Search NITRIC+OXIDE+DONATING+DRUG |
| 6 | DMBA CARCINOGENESIS | 1 | 29% | 0% | 4 | Search DMBA+CARCINOGENESIS | Search DMBA+CARCINOGENESIS |
| 7 | ECNOS | 1 | 18% | 0% | 4 | Search ECNOS | Search ECNOS |
| 8 | A172 HUMAN GLIOMA CELLS | 1 | 50% | 0% | 1 | Search A172+HUMAN+GLIOMA+CELLS | Search A172+HUMAN+GLIOMA+CELLS |
| 9 | AD293 CELLS | 1 | 50% | 0% | 1 | Search AD293+CELLS | Search AD293+CELLS |
| 10 | AEROBIC AND ANAEROBIC METABOLISMS | 1 | 50% | 0% | 1 | Search AEROBIC+AND+ANAEROBIC+METABOLISMS | Search AEROBIC+AND+ANAEROBIC+METABOLISMS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MDA MB 468 CELLS | 10 | 73% | 1% | 8 |
| 2 | SYNTHASE II GENE | 6 | 80% | 0% | 4 |
| 3 | EXPRESSING WILD TYPE | 5 | 60% | 0% | 6 |
| 4 | II GENE DISRUPTION | 4 | 75% | 0% | 3 |
| 5 | TUMOR CELL RADIOSENSITIZATION | 4 | 75% | 0% | 3 |
| 6 | CELL RADIOSENSITIZATION | 4 | 56% | 0% | 5 |
| 7 | GENERATING VASODILATORS | 3 | 21% | 1% | 14 |
| 8 | WOODCHUCK HEPATITIS VIRUS | 3 | 23% | 1% | 11 |
| 9 | PEROXYNITRITE CAUSES | 2 | 36% | 0% | 5 |
| 10 | METH A TUMOR | 2 | 67% | 0% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The role of nitric oxide in tumour progression | 2006 | 398 | 158 | 46% |
| The yin and yang of nitric oxide in cancer progression | 2013 | 40 | 144 | 49% |
| The role of nitric oxide in cancer | 2002 | 260 | 54 | 52% |
| Nitric oxide, a double edged sword in cancer biology: Searching for therapeutic opportunities | 2007 | 153 | 282 | 40% |
| Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies | 2011 | 58 | 116 | 44% |
| Nitric oxide in cancer metastasis | 2014 | 9 | 79 | 42% |
| An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer | 2007 | 95 | 40 | 50% |
| Nitric oxide and cancer: a review | 2013 | 31 | 103 | 43% |
| Nitric oxide as a bifunctional regulator of apoptosis | 1999 | 296 | 26 | 62% |
| Radical causes of cancer | 2003 | 711 | 161 | 20% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | IMMUNOL IMMUNOTHER IE CANC | 1 | 38% | 0.2% | 3 |
| 2 | ENDOGENOUS RISK TORS GRP | 1 | 100% | 0.1% | 2 |
| 3 | INFLAMMATORY DRIVEN CARCINOGENESIS | 1 | 100% | 0.1% | 2 |
| 4 | PL PHYSIOL BRANCH | 1 | 100% | 0.1% | 2 |
| 5 | CELL DEATH HUMAN DIS GRP | 1 | 30% | 0.2% | 3 |
| 6 | DISCOVER UNIT | 1 | 40% | 0.1% | 2 |
| 7 | UNIT BIOMED MAGNET ONANCE | 1 | 33% | 0.1% | 2 |
| 8 | ADV CANC | 1 | 23% | 0.2% | 3 |
| 9 | IBQM | 1 | 21% | 0.2% | 3 |
| 10 | AKH MED | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000123239 | GRP IMMUNOBIOL//HUMAN NUTR METAB DIS LIM 25//EXPT ONCOL LIM 24 |
| 2 | 0.0000113079 | MOL INNOVAT DRUG DISCOVERY//N HYDROXYGUANIDINES//LERNER FDN |
| 3 | 0.0000109513 | ENDONUCLEASE V//S CAROLINA EXPT STN//OXANINE |
| 4 | 0.0000106474 | DIAZENIUMDIOLATE//JS K//DIAZENIUMDIOLATES |
| 5 | 0.0000106474 | ZENTRUM PHARMAKOL//URINARY NITRITE NITRATE//AIDS PATHOGENESIS MOL THER EUT |
| 6 | 0.0000103791 | MTNOS//MITOCHONDRIAL NITRIC OXIDE SYNTHASE//OXYGEN METAB |
| 7 | 0.0000098564 | S NITROSOTHIOLS//S NITROSYLATION//S NITROSOGLUTATHIONE |
| 8 | 0.0000094050 | NO ASPIRIN//NITROASPIRIN//NCX 4016 |
| 9 | 0.0000092937 | TYPE I INTERLEUKIN 1 RECEPTOR//INOS PROMOTER//ORG SCI TECHNOL |
| 10 | 0.0000067908 | CALPAIN 9//CT26 COLORECTAL ADENOCARCINOMA//DELTA PSIM |